期刊文献+

基于“益肾清利活血法”治疗的慢性肾脏病3期病人的转归分析 被引量:5

Outcome Analysis of Patients with Stage 3 Chronic Kidney Disease Treated with"Kidney-Tonifying Blood-Activating Method"
下载PDF
导出
摘要 目的研究经过"益肾清利活血法"治疗的慢性肾脏病3期(Chronic Kidney Disease 3,CKD3)期患者分期转归情况,分析其与患者临床特点的相关性。方法纳入符合要求的CKD分期逆转组和未逆转组患者共69例,对两组患者一般情况、临床特点及随诊情况等比较分析。结果(1)两组患者一般情况无统计学差异,但逆转组患者就诊时肾损伤指标较低、蛋白尿更少、贫血及肾萎缩程度较轻,差异有统计学差异。(2)中医证候方面,两组患者就诊时本虚证无明显差异,邪实证中逆转组患者以湿浊证为主,未逆转组以湿热证为主。(3)两组患者随诊情况比较,未逆转组加入慢病管理患者比例更高,逆转早的患者逆转后维持时间更长,且具有统计学意义。结论孙伟教授"益肾清利活血法"可以有效延缓和逆转CKD3期患者肾脏病分期进展,但因患者临床特点及随诊情况不同而有差异。 Objective To study the stage outcome of chronic kidney disease stage 3(CKD3)patients treated by"Tonifying kidney,clearing blood and promoting blood circulation method",and to analyze its correlation with the clinical characteristics of patients.Methods A total of 69 patients who met the requirements of CKD stage reversal group and non-reversal group were included.The general condition,clinical characteristics and follow-up of the two groups were compared and analyzed.Results(1)There was no statistical difference in general conditions between the two groups,but patients in the reversal group had lower renal injury indexes,less proteinuria,less anemia and less renal atrophy,and the differences were statistically significant.(2)In terms of TCM syndromes,there was no significant difference between the two groups of patients in the treatment of this deficiency syndrome.In the evil demonstration,patients in the reverse group were mainly characterized by dampness and turbidity,while those in the non-reverse group were mainly characterized by dampness and heat.(3)Comparison of patients′follow-up between the two groups showed that the proportion of patients with chronic disease management in the non-reversal group was higher,and patients with early reversal lasted longer after reversal,which was statistically significant.Conclusion Professor Sun Wei′s method of"Kidney-Tonifying Blood-Activating Method"can effectively delay and reverse the stage progression of kidney disease in patients with CKD3,but there are differences due to different clinical characteristics and follow-up of patients.
作者 王玉婵 孙伟 Wang Yuchan;Sun Wei(The Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210000,China)
出处 《世界科学技术-中医药现代化》 CSCD 北大核心 2021年第10期3454-3461,共8页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 国家中医药管理局重大疑难病中西医临床协作试点项目(国中医药办医政发【2018】3号):慢性肾功能衰竭,负责人:孙伟 江苏省中医药局江苏省名老中医药专家传承工作室项目(苏中医教科【2019】10号):孙伟传承工作室,负责人:陈继红 江苏省人民政府江苏省高校优势学科项目(ZYX03KF075):江苏省高校优势学科项目中医肾病中心建设,负责人:孙伟。
关键词 CKD3期 中医药 益肾清利活血 分期逆转 CKD3 stage Traditional Chinese medicine Kidney-tonifying blood-activating function Staging reversal
  • 相关文献

参考文献14

二级参考文献147

共引文献356

同被引文献91

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部